Skip to main content

Table 7 Positive blood culture and SeptiFast®: Isolated pathogens per patient with positive blood culture and positive SF result

From: Clinical impact of a commercially available multiplex PCR system for rapid detection of pathogens in patients with presumed sepsis

Identified pathogen Therapeutical relevance
Escherichia coli No change: patient deceased before results became available, empirical therapy sufficient
Coagulase negative staphylococci Modification necessary: Vancomycin added
Serratia marcescens No change, empirical therapy sufficient
Staphylococcus aureus No change, BC results leading to change were available before SF
Serratia marcescens No change, empirical therapy started after sample collection sufficient
Enterococcus faecium Modification necessary: Vancomycin added
Klebsiella pneumoniae No change, empirical therapy sufficient
Candida tropicalis No change, empirical therapy started after sample collection sufficient
Staphylococcus aureus No change, empirical therapy sufficient
Proteus mirabilis No change, empirical therapy sufficient
Enterococcus faecalis No change, empirical therapy sufficient
Candida albicans Modification necessary: Fluconazole added
Staphylococcus aureus No change, empirical therapy sufficient
Escherichia coli No change: patient deceased before results became available, empirical therapy sufficient
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us